Crimean-Congo haemorrhagic fever (CCHF) virus-specific antibody detection in blood donors, Castile-Leon, Spain, summer 2017 and 2018
EUROSURVEILLANCE
Authors: Monsalve Arteaga, Lia; Munoz Bellido, Juan Luis; Vieira Lista, Maria Carmen; Vicente Santiago, Maria Belen; Fernandez Soto, Pedro; Bas, Isabel; Leralta, Nuria; de Ory Manchon, Fernando; Isabel Negredo, Ana; Sanchez Seco, Maria Paz; Alonso Sardon, Montserrat; Perez Gonzalez, Sonia; Jimenez del Bianco, Ana; Blanco Peris, Lydia; Alamo-Sanz, Rufino; Hewson, Roger; Belhassen-Garcia, Moncef; Muro, Antonio
Abstract
Crimean-Congo haemorrhagic fever virus (CCHFV) is considered an emerging or even a probable re-emerging pathogen in southern Europe. Presence of this virus had been reported previously in Spain in 2010. Aim: We aimed to evaluate the potential circulation of CCHFV in western Spain with a serosurvey in asymptomatic adults (blood donors). Methods: During 2017 and 2018, we conducted a CCHFV serosurvey in randomly selected asymptomatic blood donors from western Spain. Three assays using specific IgG antibodies against CCHFV were performed: the VectoCrimea ELISA test, an in-house ELISA and indirect immunofluorescence (Eurolmmun) test with glycoprotein and nucleoprotein. Results: A total of 516 blood donors participated in this cross-sectional study. The majority of the study participants were male (68.4%), and the mean age was 46.3 years. Most of the participants came from rural areas (86.8%) and 68.6% had contact with animals and 20.9% had animal husbandry practices. One in five participants (109/516, 21.1%) were engaged in at-risk professional activities such as agriculture and shepherding, slaughtering, hunting, veterinary and healthcare work (mainly nursing staff and laboratory technicians). A total of 15.3% of the participants were bitten by ticks in the days or months before the date of sampling. We detected anti-CCHFV IgG antibodies with two diagnostic assays in three of the 516 individuals and with one diagnostic assay in six of the 516 individuals. Conclusion: Seroprevalence of CCHFV was between 0.58% and 1.16% in CastileLeon, Spain. This is the first study in western Spain that showed circulation of CCHFV in healthy people.
A one-step multiplex real-time RT-PCR for the universal detection of all currently known CCHFV genotypes
JOURNAL OF VIROLOGICAL METHODS
Authors: Sas, Miriam A.; Vina-Rodriguez, Ariel; Mertens, Marc; Eiden, Martin; Emmerich, Petra; Chaintoutis, Serafeim C.; Mirazimi, Ali; Groschup, Martin H.
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a fatal disease in humans, which is endemic in many countries of Africa, Southern Asia and Southeastern Europe. It is caused by the Crimean-Congo hemorrhagic fever virus (CCHFV), which is an arthropod-borne virus (arbovirus) transmitted by ixodid ticks, mainly of the genus Hyalomma. Animals like hares, hedgehogs, cattle, camels and small ruminants can become infected without developing clinical signs. Seroconversion occurs after a short viremia of up to two weeks, and thus seroprevalence studies in ruminants can be used to reveal risk areas for the human population. Virus detection by real-time quantitative reverse transcription polymerase chain reaction (RT-qPCR) is essential to prove an actual circulation of CCHFV in a country and is also used as diagnostic method for acute human CCHFV infections. In this study, a new universal one-step multiplex real-time RT-qPCR for the sensitive and specific detection of CCHFV is presented. For this purpose, 14 new primers and 2 probes were simultaneously used to detect RNAs representing all six CCHFV genotypes. Additionally, a GC-mirrored sequence within the synthetic RNAs enables the discrimination between true positive samples and unintentional laboratory contaminations. CCHFV negative samples from different animal species and ten different members of the order Bunyavirales were eventually tested to reveal the specificity of the new RT-qPCR.